Cite

HARVARD Citation

    Katoh, R. et al. (2023). Significance of serum IP‐10/CXCL10 measurement in predicting post‐direct acting antiviral treatment liver function in patients with HCV‐decompensated liver cirrhosis. Hepatology research. 53 (4), pp. 280-288. [Online]. 
  
Back to record